<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:mpath ids='MPATH_3'>Apoptosis</z:mpath> is one of the major mechanisms of cell <z:hpo ids='HP_0011420'>death</z:hpo> during <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> and reperfusion injury </plain></SENT>
<SENT sid="1" pm="."><plain><z:chebi fb="0" ids="5130">Flurbiprofen</z:chebi> has been shown to reduce <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo>/reperfusion injury in both focal and global <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> models, but the mechanism remains unclear </plain></SENT>
<SENT sid="2" pm="."><plain>This study aimed to investigate the potential association between the neuroprotective effect of <z:chebi fb="0" ids="5130">flurbiprofen</z:chebi> and the <z:mpath ids='MPATH_3'>apoptosis</z:mpath> inhibiting signaling pathways, in particularly the Akt/GSK-3β pathway </plain></SENT>
<SENT sid="3" pm="."><plain>A focal <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> rat model was subjected to middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> (MCAO) for 120 min and then treated with <z:chebi fb="0" ids="5130">flurbiprofen</z:chebi> at the <z:hpo ids='HP_0003674'>onset</z:hpo> of reperfusion </plain></SENT>
<SENT sid="4" pm="."><plain>The <z:mpath ids='MPATH_124'>infarct</z:mpath> volume and the neurological deficit scores were evaluated at 24h after reperfusion </plain></SENT>
<SENT sid="5" pm="."><plain>Cell <z:mpath ids='MPATH_3'>apoptosis</z:mpath>, <z:mpath ids='MPATH_3'>apoptosis</z:mpath>-related proteins and the levels of p-Akt and p-GSK-3β in ischemic penumbra were measured using TUNEL and western blot </plain></SENT>
<SENT sid="6" pm="."><plain>The results showed that administration of <z:chebi fb="0" ids="5130">flurbiprofen</z:chebi> at the doses of 5 and 10mg/kg significantly attenuated <z:e sem="disease" ids="C0007786" disease_type="Disease or Syndrome" abbrv="">brain ischemia</z:e>/reperfusion injury, as shown by a reduction in the <z:mpath ids='MPATH_124'>infarct</z:mpath> volume, neurological deficit scores and cell <z:mpath ids='MPATH_3'>apoptosis</z:mpath> </plain></SENT>
<SENT sid="7" pm="."><plain>Moreover, <z:chebi fb="0" ids="5130">flurbiprofen</z:chebi> not only inhibited the expression of Bax protein and p-GSK-3β, but also increased the expression of Bcl-2 protein, the ratio of Bcl-2/Bax as well as the P-Akt level </plain></SENT>
<SENT sid="8" pm="."><plain>Taken together, these results suggest that <z:chebi fb="0" ids="5130">flurbiprofen</z:chebi> protects the brain from <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>/reperfusion injury by reducing <z:mpath ids='MPATH_3'>apoptosis</z:mpath> and this neuroprotective effect may be partly due to the activation of Akt/GSK-3β signaling pathway </plain></SENT>
</text></document>